Society of Toxicology 2008 Annual Meeting
Mar 16, 2008 , Seattle, WA

Posters

Monday, March 17, 2008

9:00am-12:30pm, Poster Board #518, Abstract #250
Generation and Validation of Multi-gene Validated Biomarkers for Prediction and Diagnosis of Bile Duct Hyperplasia in Rats, Jeffy BD, Blomme E (Abbott) and Yang Y (Abbott).

9:00am-12:30pm, Poster Board #519, Abstract #251
Third-party Biomarker Validation and Hypothesis Generation in a Very Large Toxicogenomic Database, Gollub J, Jeffy B, Pearson C, Halbert DN, and Roter AH.

Wednesday, March 19, 2008

9:00am-12:30pm, Poster Board #515, Abstract #1578
Toxicogenomic Comparison of Rat Liver and Primary Hepatocytes Following Compound Exposure, Yang A, Pearson C, Gollub J, Vladimirova A.

1:00pm-4:30pm, Poster Board #629, Abstract #1931
Identification and Characterization of Novel AhR Ligands across Species, Sorrentino C (UC Davis), Hu W, Fielden M (Roche) and Denison MS (EPA).

http://www.toxicology.org/ai/meet/am2008/index.asp

Society of Toxicology 2007 Annual Meeting
Mar 26, 2007 , Charlotte, NC USA

Platform Session

Wednesday, March 28, 2007

9:24 AM - 9:48 AM, Room 207C (Charlotte Convention Center)
Evaluation Of Cardiotoxicity Potential Of The Cancer Therapeutic Agent Gleevec Based On Gene Expression Data In Rat, Vladimirova A, Halbert DN and Fielden M.

Posters

Monday, March 26, 2007

9:30am-12:30pm, Poster Number 257-432
A Chemogenomic Analysis Of The Drug-Drug Interaction Between Statins And Fibrates, Lee MD, Ganter B, Jarnagin K and Halbert DN.

1pm-4:30pm, Poster Number 456-403
Toxicogenomics Analysis Correlates Attenuation Of Nrf2 Function With Renal Toxicity In The Rat, Gong L, Hu W, Halbert DN and Lee MD.

1pm-4:30pm, Poster Number 459-406
Toxicogenomic Investigation Of Mechanisms And Markers Of Nephrotoxicity By Incorporating Laser Capture Microdissection And A Contextual Microarray Database, Yang AH1, Ramiro-Ibanez F2, Fuentealba C2, Vladimirova A1 and Jessen B2.

Tuesday, March 27, 2007

1pm-4:30pm, Poster Number 1024-129
Human PBMCs As An In Vitro Model For Identifying Human Biomarkers To Predict Mechanisms Of Compound Induced Toxicity, Patil NS, Brady L, Brown S, Faravashi N, Eynon B, Gollub J, Nair R, Fujimoto S, Day GJ, Halbert DN.

Thursday, March 29, 2007

8:30am-12:00pm, Poster number: 1945-161
Gene Expression-Based Prediction And Mechanistic Assessment Of Non-Genotoxic Chemical-Induced Hepatocarcinogenicity, Fielden M, Brennan R., Gollub J.

http://www.toxicology.org/ai/meet/am2007/index.asp

Society of Toxicology 2006 Annual Meeting
Mar 5, 2006 , San Diego, CA USA

Platform Sessions

Tuesday, March 07, 2006

9:00 am-12:00 pm, Rm 15A, Biomarkers: Identification and Application
9:00-9:22 am, 784. Validation of Putative Biomarkers for the Early Prediction of Non-Genotoxic Hepatocarcinogenesis and Comparison to Drug Signatures, M. R. Fielden et al.

10:06-10:28 am, 787. Cyp1a1 Induction and Aryl Hydrocarbon Receptor Activation: Death Penalty for Preclinical Drug Candidate? C. Sorrentino (UC Davis) et al.

1:30-3:45 pm, Rm 11A, Affymetrix Workshop, Removing the Barriers to Widespread Adoption of Toxicogenomics in Drug Discovery, J. Retief.

Wednesday, March 8, 2006

1:30-4:30pm, Rm15A, Bioinformatics and Biological Modeling
2:58-3:20 pm, 1889. A Small Number of Genes are Sufficient to Classify a Large Number of Unique Toxicological and Pharmacological End-points Using Gene Expression, G. Natsoulis et al.

1:30-4:30 pm, Rm 2, Predicting Compound Toxicity
3:20-3:42 pm, 1907. Human PBMCs as an In Vitro Model for Predicting Compound Toxicity, N. Patil et al.

Thursday, March 9, 2006

9:00-am-12:00 pm, Rm 8, Application of Genomics to Evaluating Mechanisms of Genotoxicity and Carcinogenicity, R. J. Brennan (symposium co-chair)
10:20-10:55 am, 2219. Development and application to drug discovery of gene expression biomarkers for genotoxicants and carcinogens, R. J. Brennan.

Posters

Monday, March 06, 2006

9:30am-12:00 pm, Exhibit Hall, Biomarkers
169. Hepatic transcriptome differentiates a selective PDE4 inhibitor and identifies a possible mechanism of acute phase response (APR) due to loss of intestinal permeability, R. Eyre (ICOS) et al.
182. Blood as a Toxicogenomic tissue, C. Pearson et. al.

Tuesday, March 07, 2006

9:00am-12:00 pm, Exhibit Hall, Bioinformatics
987. Motif Technology and Applications in Understanding the Mechanism of Drug Toxicity and Action, A.Vladimirova et al.
993. Genomic effects of diet restriction and
drug-induced hepatotoxicity in male rat liver,
S. Burel (Neucrocrine) et al.

1:30-4:30 pm, Exhibit Hall, Gene Regulation I
1358. Relationship between drug-induced iNOS-2 gene induction and p450 gene repression: mechanistic differences among drug classes, B. Ganter R. D. Snyder (Schering-Plough) et al.

Thursday, March 09, 2006

9:00am-12:00 pm, Rm 6ABCF, Liver III
2392. Characterization of compound-induced
hepatotoxicity using gene expression profiling in rat primary hepatocytes, G. Day, T. P. Ryan (Lilly) et. al.
2337. Toxicogenomic Study of Triazole Fungicides, W. Hu, D. Dix (EPA) et al.

http://www.toxicology.org/ai/meet/am2006/index.asp